• Profile
Close

Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer

Journal of Magnetic Resonance Imaging Mar 05, 2019

Horvat JV, et al. - In invasive breast cancer, researchers ascertained if receptor status, proliferation rate, and molecular subtype can be predicted by different apparent diffusion coefficient (ADC) metrics. In this retrospective study, two readers drew a region of interest on the whole tumor (WTu) and its darkest part (DpTu) on ADC maps independently. Both readers had significantly different ADC values for estrogen receptor (ER) and progesterone receptor (PR) status. Findings suggested that maximum WTu ADC values can be used to distinguish luminal from other breast cancer molecular subtypes. For both readers, other approaches and metrics for ADC measurement were not significantly different in determining immunohistochemical status, molecular subtype, and Ki-67 proliferation rate.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay